Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAMMER: Human Amnion Membrane Allograft for Erectile Function After Radical Prostatectomy
NCT05842057Phase 2Active, not recruiting
- Sponsor
- University of Miami
- Start
- Aug 2023
- Primary completion
- Aug 2027
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 2, randomised trial of BioDFence G3 Placental Tissue Membrane in erectile dysfunction (ED) and urinary incontinence (UI) (2 arms), sponsored by University of Miami. Primary endpoint: Change in Erectile Function Recovery as Measured by EPIC26 Sexual Domain Score at 12 months. Started Aug 2023; status: active, not recruiting.
02
Drugs
BioDFence G3 Placental Tissue Membrane
03
Conditions
erectile dysfunction (ED)urinary incontinence (UI)
Beyond the preview
Go deeper on NCT05842057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05842057.